These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18205876)

  • 41. Late onset systemic sclerosis with seronegativity: a rare presentation of an uncommon disease.
    Saxena D; Jain D; Yadav M; Giri K; Yadav T; Jain P
    Reumatismo; 2019 Oct; 71(3):166-170. PubMed ID: 31649382
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antinuclear Antibodies in Systemic Sclerosis: an Update.
    Stochmal A; Czuwara J; Trojanowska M; Rudnicka L
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):40-51. PubMed ID: 30607749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
    Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
    Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Autoantibodies in systemic sclerosis: clinical interest and diagnosis approach].
    Admou B; Essaadouni L; Amal S; Arji N; Chabaa L; El Aouad R
    Ann Biol Clin (Paris); 2009; 67(3):273-81. PubMed ID: 19411229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin).
    Falkner D; Wilson J; Fertig N; Clawson K; Medsger TA; Morel PA
    J Rheumatol; 2000 May; 27(5):1196-202. PubMed ID: 10813287
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement.
    Mitri GM; Lucas M; Fertig N; Steen VD; Medsger TA
    Arthritis Rheum; 2003 Jan; 48(1):203-9. PubMed ID: 12528120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiopulmonary Disease Development in Anti-RNA Polymerase III-positive Systemic Sclerosis: Comparative Analyses from an Unselected, Prospective Patient Cohort.
    Hoffmann-Vold AM; Midtvedt Ø; Tennøe AH; Garen T; Lund MB; Aaløkken TM; Andreassen AK; Elhage F; Brunborg C; Taraldsrud E; Molberg Ø
    J Rheumatol; 2017 Apr; 44(4):459-465. PubMed ID: 28089974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests.
    Mahler M; Satoh M; Hudson M; Baron M; Chan JY; Chan EK; Wick J; Fritzler MJ;
    J Rheumatol; 2014 Jul; 41(7):1334-43. PubMed ID: 24931955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay.
    Satoh T; Ishikawa O; Ihn H; Endo H; Kawaguchi Y; Sasaki T; Goto D; Takahashi K; Takahashi H; Misaki Y; Mimori T; Muro Y; Yazawa N; Sato S; Takehara K; Kuwana M
    Rheumatology (Oxford); 2009 Dec; 48(12):1570-4. PubMed ID: 19808694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical setting of patients with systemic sclerosis by serum autoantibodies.
    Picillo U; Migliaresi S; Marcialis MR; Ferruzzi AM; Tirri G
    Clin Rheumatol; 1997 Jun; 16(4):378-83. PubMed ID: 9259252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-PM-Scl antibody in patients with systemic sclerosis.
    Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis.
    Fertig N; Domsic RT; Rodriguez-Reyna T; Kuwana M; Lucas M; Medsger TA; Feghali-Bostwick CA
    Arthritis Rheum; 2009 Jul; 61(7):958-65. PubMed ID: 19565553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies.
    Landon-Cardinal O; Baril-Dionne A; Hoa S; Meyer A; Leclair V; Bourré-Tessier J; Mansour AM; Zarka F; Makhzoum JP; Nehme J; Rich E; Goulet JR; Grodzicky T; Koenig M; Joyal F; Richard I; Hudson M; Targoff I; Satoh M; Fritzler MJ; Troyanov Y; Senécal JL
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32892170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis.
    Pauling JD; Salazar G; Lu H; Betteridge ZE; Assassi S; Mayes MD; McHugh NJ
    Rheumatology (Oxford); 2018 Apr; 57(4):712-717. PubMed ID: 29294089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis.
    Dick T; Mierau R; Bartz-Bazzanella P; Alavi M; Stoyanova-Scholz M; Kindler J; Genth E
    Ann Rheum Dis; 2002 Feb; 61(2):121-7. PubMed ID: 11796397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis?
    Chepy A; Bourel L; Koether V; Launay D; Dubucquoi S; Sobanski V
    Front Immunol; 2022; 13():930970. PubMed ID: 35837382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of anti-RNA polymerase III antibodies in Chinese Han systemic sclerosis patients.
    Liu C; Hou Y; Xu D; Li L; Zhang Y; Cheng L; Yan S; Zhang F; Li Y
    Clin Rheumatol; 2020 Apr; 39(4):1191-1197. PubMed ID: 31858335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis.
    Sharif R; Fritzler MJ; Mayes MD; Gonzalez EB; McNearney TA; Draeger H; Baron M; ; Furst DE; Khanna DK; del Junco DJ; Molitor JA; Schiopu E; Phillips K; Seibold JR; Silver RM; Simms RW; ; Perry M; Rojo C; Charles J; Zhou X; Agarwal SK; Reveille JD; Assassi S; Arnett FC
    J Rheumatol; 2011 Aug; 38(8):1622-30. PubMed ID: 21572159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Low prevalence of anti-centromere antibodies in scleroderma in Morocco (about 272 cases)].
    Admou B; Arji N; Seghrouchni F; Missoum H; El Fenniri L; Amghar S; El Aouad R
    Ann Biol Clin (Paris); 2007; 65(3):291-7. PubMed ID: 17502303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.